330 filings
Page 4 of 17
8-K
yg5h2 0gr
3 Nov 21
Aurinia Reports Third Quarter and Nine Months 2021 Financial Results and Company Updates
12:00am
8-K/A
47uv6hgy55484m5n2
17 Sep 21
Submission of Matters to a Vote of Security Holders
4:03pm
8-K
a92x0 4l9fncw
17 Aug 21
Riptide Aurinia Collaboration & License Agreement
4:07pm
8-K
syk keb02yqk8
5 Aug 21
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
4:12pm
8-K
u7trs7z7b jscv
5 Aug 21
Aurinia Reports Second Quarter and Six Months 2021 Financial Results and Recent Operational Highlights
4:11pm
8-K
3pfrzq
19 Jul 21
Aurinia Pharmaceuticals Announces Delisting from the Toronto Stock Exchange
12:00am
S-8
eqszva7nznxj
25 Jun 21
Registration of securities for employees
4:31pm
8-K
qzj9116
25 Jun 21
Regulation FD Disclosure
4:12pm
8-K
6c3xmbe rc
17 Jun 21
Aurinia Announces Addition of Dr. Brinda Balakrishnan to the Board of Directors
4:36pm
8-K
3g9cv8vtptrjsujt 0s
10 Jun 21
Departure of Directors or Certain Officers
4:08pm
DEF 14A
bmcyc
10 May 21
Definitive proxy
4:06pm
10-Q
dbf0mnuusfdm vf
6 May 21
Quarterly report
4:14pm
8-K
gbgu8uzzfb6h ga
6 May 21
Aurinia Reports First Quarter 2021 Financial Results and Recent Operational Highlights
4:08pm
10-K/A
n8l9 kc9b
30 Apr 21
Annual report (amended)
4:16pm
PRE 14A
gmxc746 1x3
27 Apr 21
Preliminary proxy
4:32pm
8-K
i9qxw9qmspwqgivah
27 Apr 21
Amendments to Articles of Incorporation or Bylaws
4:17pm
S-8
vessd08 xo6fme
24 Feb 21
Registration of securities for employees
4:28pm
8-K
ps6uay y2m
24 Feb 21
Aurinia Reports Fourth Quarter and Full Year 2020 Financial Results and Recent Operational Highlights
4:14pm
10-K
vq02 usxgps0g2i
24 Feb 21
Annual report
4:09pm